化学
立体化学
微管蛋白
质子核磁共振
组合化学
碳-13核磁共振
索拉非尼
对接(动物)
癌细胞系
癌细胞
癌症
微管
癌症研究
生物
医学
细胞生物学
护理部
肝细胞癌
遗传学
作者
Samir M. Awad,Mosaad S. Mohamed,Marwa Abd El-Fattah Khodair,Rania H. Abd El‐Hameed
出处
期刊:Anti-cancer Agents in Medicinal Chemistry
[Bentham Science]
日期:2021-05-01
卷期号:21 (8): 963-986
被引量:4
标识
DOI:10.2174/1871520620666200925103742
摘要
Benzo[h]chromenes attracted great attention because of their widespread biological activities, including anti-proliferate activity, and the discovery of novel effective anti-cancer agents is imperative.The main objective was to synthesize new benzo[h]chromene derivatives and some reported derivatives, and then test all of them for their anti-cancer activities.The structures of the newly synthesized derivatives were confirmed by elemental and spectral analysis (IR, Mass, 1H-NMR and 13C-NMR). 35 compounds were selected by the National Cancer Institute (NCI) for single-dose testing against 60 cell lines and 3 active compounds were selected for 5-doses testing. Also, these 3 compounds were tested as EGFR-inhibitors; using sorafenib as standard, and as Tubulin polymerization inhibitors using colchicines as a standard drug. Moreover, molecular docking study for the most active derivative on these 2 enzymes was also carried out.Compounds 1a, 1c and 2b have the highest activities among all 35 tested compounds especially compound 1c.compound 1c has promising anti-cancer activities compared to the used standards and may need further modification and investigations.
科研通智能强力驱动
Strongly Powered by AbleSci AI